In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets

As islet transplantation becomes an acceptable clinical modality for restoring normoglycemia in type 1 diabetic patients, there is a crucial need for noninvasive assessment of the fate of the grafts. In spite of the success of the Edmonton Protocol, a significant graft loss occurs due to immunological and nonimmunological events immediately after transplantation. Allogeneic rejection in graft recipients is one of the major reasons for islet death and graft failure. Therefore, monitoring the islet rejection using reliable noninvasive methods would significantly aid in clinical assessment of graft success. We have previously developed a method to detect transplanted islets noninvasively using magnetic resonance imaging (MRI). For this procedure, human pancreatic islets are labeled with an MRI contrast agent that enables their visualization on magnetic resonance images. In our present study, we not only detected labeled human islets in a preclinical intrahepatic model of human islet transplantation in mice but also showed that islet rejection can be monitored noninvasively and repeatedly in real time by MRI. In addition, in this study, we have adapted, for islet cell labeling, a Food and Drug Administration–approved commercially available contrast agent, Feridex, that is used clinically for liver imaging. We believe that this agent, in combination with our preclinical model of islet transplantation, will facilitate the transition of imaging immune rejection to clinical trials.

[1]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[2]  T. Strom.  Saving islets from allograft rejection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Weissleder,et al.  Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. , 1994, Biochimica et biophysica acta.

[4]  M. Field,et al.  Effect of 15-Deoxyspergualin on Immediate Function and Long-Term Survival of Transplanted Islets in Murine Recipients of a Marginal Islet Mass , 1994, Diabetes.

[5]  G. Elgue,et al.  Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? , 1999, Diabetes.

[6]  J. Corbett,et al.  IL-1 produced and released endogenously within human islets inhibits beta cell function. , 1998, The Journal of clinical investigation.

[7]  M. Atkinson,et al.  What causes diabetes? , 1990, Scientific American.

[8]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Brunet,et al.  Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience , 1998, Bone Marrow Transplantation.

[10]  C. Mathieu,et al.  Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. , 2000, Diabetes.

[11]  A. Dalmasso,et al.  Reversal of diabetes in non‐immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection , 2004, Xenotransplantation.

[12]  Camillo Ricordi,et al.  Clinical islet transplantation: advances and immunological challenges , 2004, Nature Reviews Immunology.

[13]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[14]  A. Shapiro,et al.  Successful islet transplantation: continued insulin reserve provides long-term glycemic control. , 2002, Diabetes.

[15]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[17]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[18]  S. Bonner-Weir,et al.  Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and Function , 1996, Diabetes.

[19]  D. Jirák,et al.  Magnetic Resonance Imaging of Pancreatic Islets in Tolerance and Rejection , 2005, Transplantation.

[20]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[21]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[22]  D. D. Stark,et al.  Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. , 1990, AJR. American journal of roentgenology.

[23]  N. Barshes,et al.  islet transplantation: implications for intrahepatic grafts , 2022 .

[24]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[25]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[26]  H. Gaskins,et al.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Ricordi,et al.  Edmonton's islet success has indeed been replicated elsewhere , 2003, The Lancet.

[28]  A. Shapiro,et al.  Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.

[29]  A. Di Carlo,et al.  Hepatic Sinusoidal Endothelium Upregulates IL-1α, IFN-γ, and iNOS in Response to Discordant Xenogeneic Islets in an in Vitro Model of Xenoislet Transplantation , 2002 .

[30]  I. Shimomura,et al.  Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Peter Girman,et al.  MRI of transplanted pancreatic islets , 2004, Magnetic resonance in medicine.

[32]  R. Weissleder,et al.  Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.

[33]  C. Ricordi,et al.  Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. , 1998, Diabetes.

[34]  Jeff W M Bulte,et al.  In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  E. Montanya,et al.  Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. , 2002, Diabetes.

[36]  G. Elgue,et al.  TISSUE FACTOR RELEASED BY THE ENDOCRINE CELLS OF THE ISLETS OF LANGERHANS IS ASSOCIATED WITH A NEGATIVE OUTCOME OF CLINICAL ISLET TRANSPLANTATION , 2004, Diabetes.

[37]  C. Ricordi,et al.  Effects of graft-versus-host reaction on intrahepatic islet transplants. , 1999, Diabetes.

[38]  N. Barshes,et al.  Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. , 2004, Transplantation proceedings.

[39]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[40]  Anna Moore,et al.  In vivo imaging of islet transplantation , 2006, Nature Medicine.